KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Bristol Myers Squibb (BMY) over the last 16 years, with Q3 2025 value amounting to 0.5.

  • Bristol Myers Squibb's Asset Utilization Ratio fell 45.47% to 0.5 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5, marking a year-over-year decrease of 45.47%. This contributed to the annual value of 0.51 for FY2024, which is 972.93% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Asset Utilization Ratio of 0.5 as of Q3 2025, which was down 45.47% from 0.51 recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Asset Utilization Ratio peaked at 0.52 during Q4 2024, and registered a low of 0.37 during Q1 2021.
  • In the last 5 years, Bristol Myers Squibb's Asset Utilization Ratio had a median value of 0.48 in 2023 and averaged 0.47.
  • As far as peak fluctuations go, Bristol Myers Squibb's Asset Utilization Ratio skyrocketed by 5499.91% in 2021, and later tumbled by 226.47% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Asset Utilization Ratio stood at 0.42 in 2021, then increased by 12.37% to 0.47 in 2022, then increased by 2.0% to 0.48 in 2023, then rose by 7.4% to 0.52 in 2024, then dropped by 3.3% to 0.5 in 2025.
  • Its Asset Utilization Ratio stands at 0.5 for Q3 2025, versus 0.51 for Q2 2025 and 0.51 for Q1 2025.